Sterling® SL H74939148401210Recalls & reported problems
Boston Scientific Corporation · PTA Balloon Dilatation Catheter · Class 2
All models of Sterling SL (35)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 08714729782377), received between Mar 6, 2020 and Jan 22, 2025 — classified as 7 malfunctions.
The most frequently reported specific device problem is “Material Rupture” (5 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Material Rupture5
- Deflation Problem1
- Leak/Splash1
- Material Integrity Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 22, 2025Material Rupture; Material Rupture
IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. THE TARGET LESION WAS LOCATED IN THE DISTAL SUPERFICIAL FEMORAL ARTERY TOTAL. A 4.0MM X 120MM X 150CMSTERLING SL BALLOON CATHETER WAS ADVANCED FOR DILATION. DURING THE PROCEDURE, THE BALLOON BURSTED BEFORE IT WAS INFLATED TO NOMINAL BURST PRESSURE (NBP). THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO COMPLICATIONS WERE REPORTED, AND THE PATIENT WAS STABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21210381 ↗MalfunctionMar 24, 2024Material Rupture; Material Rupture
IT WAS REPORTED THAT BALLOON BURST OCCURRED. THE TARGET LESION WAS LOCATED IN THE SEVERELY CALCIFIED AND NON-TORTUOUS SUPERFICIAL FEMORAL ARTERY. DURING THE PROCEDURE, THE BALLOON RUPTURED UPON INITIAL INFLATION BEFORE IT REACHED THE RATED BURST PRESSURE. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO COMPLICATIONS WERE REPORTED, AND THE PATIENT WAS STABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18966545 ↗MalfunctionMay 19, 2022Material Rupture; Material Rupture
IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. THE 70% STENOSED TARGET LESION WAS LOCATED IN A SHUNT IN A NON-TORTUOUS AND MODERATELY CALCIFIED VESSEL. A 4.0MM X 120MM X 150CM STERLING SL BALLOON CATHETER WAS ADVANCED FOR DILATATION. HOWEVER, DURING INITIAL INFLATION AT NOMINAL BURST PRESSURE, THE BALLOON RUPTURED. THE DEVICE WAS PULLED SLOWLY AND CAREFULLY FROM THE PATIENT. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT STATUS WAS STABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14436964 ↗MalfunctionJun 9, 2021Leak/Splash; Material Rupture; Leak/Splash; Material Rupture
IT WAS REPORTED THAT THERE WAS A HOLE IN THE BALLOON. A 4MM X 120MM X 150CM STERLING SL BALLOON CATHETER WAS SELECTED FOR USE IN A PERIPHERAL ANGIOPLASTY PROCEDURE. WHILE INSERTING THE DEVICE OVER THE WIRE, A HOLE IN THE BALLOON WAS OBSERVED. THE DEVICE WAS NOT INTRODUCED INTO THE PATIENT'S ARTERY. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11967845 ↗MalfunctionApr 30, 2021Material Rupture; Material Rupture
IT WAS REPORTED THAT A BALLOON RUPTURE OCCURRED. VASCULAR ACCESS WAS OBTAINED VIA THE LEFT FEMORAL ARTERY. THE 30% STENOSED, 100MM IN LENGTH, 4.5MM VESSEL DIAMETER, ECCENTRIC, DE NOVO, TARGET LESION WAS LOCATED IN THE NON-TORTUOUS AND MODERATELY CALCIFIED LOWER LEFT LIMB. THE ATHERECTOMY WAS PERFORMED WITH A JETSTREAM 2.1/3 CATHETER OVER A 14 THRUWAY GUIDE. A 4.0MM X 120MM X 150CM STERLING SL WAS FLUSHED WITH A SALINE USING 10ML SYRINGE THROUGH THE WIRE CONDUIT AND A LITTLE WATER CAME OUT OF THE DISTAL END OF CATHETER. THE BALLOON WAS THEN ADVANCED WITH A THRUWAY GUIDE 14 AND INFLATED WITH AN ENCORE 26 AT 6 AND 14 ATMOSPHERES RESPECTIVELY. HOWEVER, UPON REACHING AT 10 ATMOSPHERES INSUFFLATOR BEGAN TO DROP RAPIDLY SUSPECTED WITH A BALLOON RUPTURE. ANGIOGRAPHY SHOWS LEAKING OF CONTRAST MEDIUM INSIDE BALLOON INTO THE VESSEL. THE DEVICE WAS THEN REMOVED WITHOUT DIFFICULTY AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THAT PATIENT'S STATUS WAS STABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11755427 ↗MalfunctionApr 23, 2020Deflation Problem; Deflation Problem
IT WAS REPORTED THAT THE BALLOON COULD NOT DEFLATE. A 4.00MMX120MMX150CM STERLING SL BALLOON WAS SELECTED FOR USE IN A PROCEDURE IN THE ILIAC. AFTER THE BALLOON WAS INFLATED, IT COULD NOT BE DEFLATED. NEGATIVE PRESSURE WAS ATTEMPTED SEVERAL TIMES BUT THE BALLOON WOULD NOT ENTIRELY DEFLATE. THE BALLOON EXTENDED FROM THE PROXIMAL PORTION WHEN IT WAS REMOVED. THE PROCEDURE WAS COMPLETED WITH A NEW BALLOON OF THE SAME MODEL. THERE WERE NO PATIENT COMPLICATIONS REPORTED. THE PATIENT CONDITION POST-PROCEDURE WAS GOOD.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9990670 ↗MalfunctionMar 6, 2020Material Integrity Problem; Material Integrity Problem
IT WAS REPORTED THAT RADIOPAQUE MARKER BAND WAS NOT VISIBLE UNDER FLUOROSCOPY. THE 70% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY CALCIFIED POPLITEAL ARTERY. A 4.0MM X 120MM X 150CM STERLING SL BALLOON CATHETER WAS ADVANCED FOR DILATATION. HOWEVER, DURING PROCEDURE, IT WAS NOTED THAT THE PROXIMAL RADIOPAQUE MARKER OF THE BALLOON WAS NOT VISIBLE IN FLUOROSCOPY. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS STABLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9800750 ↗
Other CATHETER, PERCUTANEOUS devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page